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ABSTRACT
Objectives: Record review is the most used method
to quantify patient safety. We systematically reviewed
the reliability and validity of adverse event detection
with record review.
Design: A systematic review of the literature.
Methods: We searched PubMed, EMBASE, CINAHL,
PsycINFO and the Cochrane Library and from their
inception through February 2015. We included all
studies that aimed to describe the reliability and/or
validity of record review. Two reviewers conducted data
extraction. We pooled κ values (κ) and analysed the
differences in subgroups according to number of
reviewers, reviewer experience and training level,
adjusted for the prevalence of adverse events.
Results: In 25 studies, the psychometric data of the
Global Trigger Tool (GTT) and the Harvard Medical
Practice Study (HMPS) were reported and 24 studies
were included for statistical pooling. The inter-rater
reliability of the GTT and HMPS showed a pooled κ of
0.65 and 0.55, respectively. The inter-rater agreement
was statistically significantly higher when the group of
reviewers within a study consisted of a maximum five
reviewers. We found no studies reporting on the
validity of the GTT and HMPS.
Conclusions: The reliability of record review is
moderate to substantial and improved when a small
group of reviewers carried out record review. The
validity of the record review method has never been
evaluated, while clinical data registries, autopsy or
direct observations of patient care are potential
reference methods that can be used to test
concurrent validity.
INTRODUCTION
Healthcare professionals are faced with the
challenge of improving patient safety by
detecting, preventing and mitigating the
occurrence of adverse events (AEs).1 2 An
AE is deﬁned as an injury that is caused by
healthcare management (rather than the
underlying disease) and results in prolonged
hospitalisation, disability at the time of dis-
charge or even in patient’s death.3 Besides
improving patient safety, transparency with
reliable and valid data is necessary for
accountability purposes.4 5 Non-valid or
unreliable instruments for quantifying
patient safety can lead to inadequate diagno-
sis of patient safety problems and subse-
quently to the implementation of inadequate
patient safety improvement interventions.
Patient record review is the most thor-
oughly studied method used to measure the
prevalence of AEs.6 Incidents, complaints
and claims reporting systems are less suitable
for counting AEs, because the amount of
AEs strongly depends on the willingness of
healthcare providers and patients to report
them. Only 3–5% of the AEs detected in
patient records are reported by healthcare
providers in hospitals.7–11 In addition, the
denominator, the related number of patients,
is difﬁcult to determine. These systems are
therefore inadequate to count the actual
number of incidents.12–14
Strengths and limitations of this study
▪ We have reviewed ∼4000 articles across five
databases on psychometric data regarding the
record review as a method to detect adverse
events.
▪ We evaluated the methodological quality of the
included studies on measurement properties
with the validated COSMIN checklist.
▪ Two instruments for record review, the Global
Trigger Tool and the Harvard Medical Practice
Study, were extensively tested on their reliability,
but data regarding the validity of these instru-
ments completely lack.
▪ The subgroup analyses were limited to the vari-
ables that were reported by the authors in the
studies that were included in our systematic
review.
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Although record review is widely accepted as the
method for quantifying AEs, data about the psychomet-
ric aspects of this method reported in previous literature
reviews are limited12 13 15 or outdated.16 Therefore, we
systematically reviewed the reliability and validity of
record review and which factors are associated with
these psychometric measures. We assumed that the inter-
rater reliability of record review was higher for studies
with a small number of reviewers, more reviewer experi-
ence and a higher training level.
METHODS
Search strategy and databases
Our literature search strategy was prespeciﬁed and
aligned with recommendations outlined in the PRISMA
(Preferred Reporting Items for Systematic Reviews and
Meta-Analyses).17 We included the study protocol in
online supplementary appendix 1.
We searched for full-text studies published until
October 2013 and updated our search in February 2015
using the following databases: PubMed (including
MEDLINE), EMBASE, CINAHL, PsycINFO and the
Cochrane Library. The references of the included
studies were manually checked, and the authors’ per-
sonal ﬁles and bibliographies of previously published
related reviews were searched to identify additional rele-
vant studies (snowballing). There were no language
restrictions. Online supplementary appendix 2 provides
a detailed listing of search strings.
Selection criteria and process
Two researchers (MH-S and MZ) independently screened
the titles and abstracts of all studies identiﬁed by the
search strategy for their eligibility. Studies were included
if (1) the record review method was described in detail,
(2) AEs were measured in a wide variety of patient groups
and (3) data about reliability and validity were reported.
Studies not available in full-text were excluded.
When the title and abstract did not clearly indicate
whether the inclusion criteria were met, the full text
(meaning the complete article) was obtained and
reviewed by two researchers (MH-S and MZ). The previ-
ously described inclusion criteria were applied again,
and a ﬁnal set of studies was identiﬁed for data extrac-
tion. Disagreement about inclusion was solved by discus-
sion. When no consensus could be achieved, a third
researcher (HW) made the ﬁnal decision.
Terminology and definitions
Different types of reliability and validity of measurement
instruments can be distinguished. Focus of our system-
atic review was on the inter-rater reliability, content
(face) validity and concurrent validity of record review.
Deﬁnitions are described in table 1.
Quality assessment
Assessment of the methodological quality of the selected
studies was carried out using the COSMIN checklist.20
The COSMIN checklist facilitates a separate judgement
of the methodological quality of the included studies
and their results.21 The COSMIN checklist consists of
nine boxes with methodological standards for how each
measurement property should be assessed. Three of the
nine boxes were relevant for this systematic review
regarding inter-rater reliability, content validity and con-
current validity. There are no standards for assessing
face validity, because face validity requires a subjective
judgement of experts.22 Each item in these relevant
boxes was scored on a four-point rating scale (ie, ‘poor’,
‘fair’, ‘good’ or ‘excellent’).20 21 An overall score for the
methodological quality of a study was determined by
taking the lowest rating of any of the items in a box. The
methodological quality of a study was assessed per meas-
urement property by MH-S, and 10% of the studies were
assessed independently by MZ. In cases of disagreement,
a third reviewer (HW) was consulted for a ﬁnal decision.
Data extraction
Each article that met study eligibility criteria was independ-
ently abstracted by one reviewer (MH-S), and a second
reviewer (MZ) crosschecked the data extraction of the ﬁrst
reviewer. Both reviewers used a standardised form, which
compromised a description of objectives, study population,
Table 1 Definitions of reliability and validity in the context of record review
Terms Definition (expressed by) Comments relevant to record review
Inter-rater
reliability18
Measures consensus in the scores when different
raters using the same measurement instrument in the
same group of patients. Mostly expressed as a
reliability measure (κ), or % agreement
Two independent reviewers assess patient records
without discussion between the reviewers during
the review process
Face validity18 The degree to which the content of an instrument is
an adequate reflection of the construct to be
measured (descriptive, expert opinion)
Concurrent
validity19
The extent to which scores on a new measure are
related to scores from a criterion measure
administered at the same time (Se, Sp, PPV and
NPV)
Clinical data registries, autopsy or direct
observations of patient care have the potential to
be a criterion measure for record review
NPV, negative predictive value; PPV, positive predictive value; Se, sensitivity; Sp, specificity;
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design and methods used and the results of the analysis of
the reliability and validity, including statistical parameters
(see online supplementary appendix 1).
Data synthesis and analysis
We tabulated study characteristics and outcomes such as
setting, number of records, percentage AEs and data
about reliability and validity of record review. In some
studies, percentage agreement was calculated from
source data by MH-S and conﬁrmed by MZ. To be able to
rate the reliability of record review, we classiﬁed the κ
values as ‘slight’ (κ=0.00–0.20), ‘fair’ (κ=0.21–0.40),
‘moderate’ (κ=0.41–0.60), ‘substantial’ (κ=0.61–0.80)
and ‘almost perfect’ (κ=0.81–1.00).23
We pooled the outcomes statistically by calculating the
mean percentage agreement and the mean and pooled
κ on the presence of AEs to draw conclusions about the
reliability of record review. We used the number of
records on which the κ value is calculated as weighing
factor in the statistical pooling as a proxy for accuracy,
since we missed information about the 95% CIs of the κ
values in the included studies.
To examine differences in κ values depending on the
number of reviewers, reviewer experience and reviewer
training, we present descriptive statics per subgroup
(mean with SD or median with IQR for non-normal dis-
tributions, minimum and maximum). In order to better
interpret the results, we classiﬁed the number of
reviewers per study, reviewer experience and reviewer
training into three proportional classes: maximum 5
reviewers, >5–20 reviewers, >20 reviewers; <100 records
per reviewer, 100–300 records per reviewer, >300 records
per reviewer and <1 day training, 1 day training, >1 day
training, respectively. We used the non-parametric
Kruskal-Wallis test for the group characteristics, which are
not normally distributed and an ANOVA for the group
characteristics with a normal distribution. We checked
whether the assumptions for ANCOVA were met. It was
not possible to incorporate all variables (the number of
reviewers, reviewer experience and reviewer training) in
one ANCOVA, because the number of studies in our ana-
lyses was limited (n=20). Therefore, we performed three
separate ANCOVAs, with prevalence of AE as covariate.
We adjusted for prevalence of AEs, since a previous study
of Lilford et al16 showed correlation between prevalence
and κ. Additionally, we studied the inﬂuence of the aim
of the study and the type of instrument (Global Trigger
Tool (GTT) vs Harvard Medical Practice Study (HMPS))
on κ with two separate ANCOVAs adjusted for prevalence.
A p value of <0.05 was regarded as statistically signiﬁcant.
Statistical software IBM SPSS V.22 was used for all statis-
tical analyses and data processing.
RESULTS
Results of the literature search
Our literature study yielded 3915 citations (see online
supplementary appendix 3, ﬂow chart), of which 1790
were in PubMed, 1153 were in EMBASE, 515 were in
CINAHL, 30 were in PsycINFO and 427 were in the
Cochrane Library. After removing duplicates, 3415
studies remained, of which 148 were selected for full-text
selection. A total of 137 studies were excluded after
reading the full text, because these studies did not meet
the inclusion criteria, including studies that did not
focus on the reliability or validity of record review,24–26
did not have AEs as outcome27 or reported a different
method than retrospective reviewing of medical
records.28 29 We collected eight additional articles
through manual searching of articles’ bibliographies. In
February 2015, we updated our search and found six
additional studies. The ﬁnal set consisted of 25 record
review studies; 24 studies were used for calculating the
mean κ, and 20 studies were appropriate for the sub-
group analysis. Five studies were excluded because only
the intraclass correlation coefﬁcient was calculated,30
the prevalence was an outlier,31 the prevalence was not
reported32 33 or the number of reviewers was not
reported.3
Description of the GTT and the HMPS
We found two record review instruments for detecting
AEs, namely, the GTT and the HMPS. Both instruments
use an implicit review style, meaning that the AE assess-
ment relies on expert judgement instead of using well-
deﬁned criteria on a checklist (explicit review style).6 16
The GTT and the HMPS consist of a two-stage review
process conducted by nurses and physicians (table 2).
The GTT is primarily used as a quality improvement
tool for clinical practice and for estimating and tracking
AE rates over time in a hospital or a clinic. The HMPS is
commonly used to measure the prevalence rate of AEs
on a national level. The GTT is not meant to identify
every single AE in a patient record, and, therefore,
assessments have a time limit of 20 min per record.34
The GTT consists of 47–55 triggers to identify potential
AEs. Reviewing the preventability of adverse events is ori-
ginally no part of the GTT method, but has been
recently included in the studies of Schildmeijer et al,35
Kennerly et al,36 Najjar et al37 and Hwang et al.38 In con-
trast, the HMPS consists of 16–18 screening criteria (trig-
gers), 27 leading questions for AE detection, of which
three questions are crucial for AE determination: injury
present; resulting in prolongation of hospital stay, tem-
porary or permanent disability or death and caused by
healthcare management. Determination of preventabil-
ity of AEs is standard within the HMPS method. The
HMPS is more time-consuming and labour-intensive in
assessing AEs (stage 2) than the GTT, due to the
number of questions.
Characteristics and methodological quality of included
studies
Most of the identiﬁed studies were carried out in the
USA, UK, Canada, Europe and Australia (see online sup-
plementary appendices 4 and 5). In these studies, the
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Table 2 Description of the Global Trigger Tool and Harvard Medical Practice Study
Instrument Description Safety outcomes Conducted by Scale
Global Trigger
Tool34
Two-stage retrospective record review
Stage 1: Screening records for the
presence of triggers and determining
the adverse event that caused harm to
patients
Triggers (mostly
narrow)
Stage 1: Trained nurses or
hospital pharmacists (primary
reviewers, mostly two reviewers
per records)
Maximum 20 min per record
Dichotomous: yes/no trigger
Stage 2: Confirming or dismissing the
occurrence and category of the
adverse event
Adverse events Stage 2: Trained physicians
(second reviewers, mostly one
reviewer)
Dichotomous: yes/no AE
Definition of AE: Any unintended physical injury
resulting from or contributed to by medical care that
requires additional monitoring, treatment or
hospitalisation or that results in death
Medical record
review based on
HMPS3
Two-stage or three-stage retrospective record review
Stage 1: Screening records using
criteria
(Broad) Screening
criteria (triggers)
Stage 1: Trained nurses*
No time limit
Dichotomous: yes/no trigger
Stage 2: Detailed review to confirm the
presence of adverse events and their
preventability
(Preventable)
Adverse events
Stage 2: Trained physicians (one
or two reviewers per record)
AE determination is based on three criteria:
1. Unintended injury to the patient (dichotomous:
yes/no)
2. Resulted in prolongation of hospital stay,
temporary or permanent disability or death
(dichotomous: yes/no)
3. Caused by healthcare management (six-point
scale)
Preventability: six-point scale
When criteria 1 and 2 are met and the score on
criteria 3 is ≥4, then there has been an AE and an
AE is preventable when the score on the
preventability scale is ≥4
Stage 3: Discussion or independently
supervising review (consensus stage)†
Stage 3: Supervising physician
*With the exception of the study of Brennan et al,32 in which medical records were reviewed by medical-record-room administrators.
†In some studies, a third stage was used.3 32 39–42
AEs, adverse events; HMPS, Harvard Medical Practice Study.
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GTT (n=10 studies) and HMPS (n=15 studies) were all
tested in hospitals. The percentage AEs in GTT studies
ranged from 7.2% to 27.0% (see online supplementary
appendix 4). The total number of reviewers varied from
2 to 20 reviewers per study. Reviewers assessed 50 to
4043 records on average. The percentage AEs in HMPS
studies ranged from 2.9% to 18.0%, and for preventable
AEs they ranged from 1% to 8.6% (see online supple-
mentary appendix 5). The total number of reviewers
varied from 2 to 127 reviewers per study. Average records
per reviewer ranged from 38 to 3872 records. The
primary aim of most of the GTT studies included in this
review was to examine the inter-rater reliability, whereas
the primary aim of the HMPS studies reporting inter-
rater reliability data was measuring AE rates.
The methodological quality of the included
studies3 11 30–33 35–58 was good. In all these studies, the
inter-rater reliability was evaluated. In one study, the face
validity was evaluated.32
Reliability of the GTT
The percentage agreement for reviewers of AE assess-
ment was reported in four studies,31 38 43 47 ranging
from 83% to 94% with a mean of 87.5% (SD 4.8%) (see
online supplementary appendix 4). One study showed
fair inter-rater reliability (κ=0.34),47 two studies showed
moderate inter-rater reliability (κ=0.45),35 43 ﬁve studies
showed substantial inter-rater reliability (κ=0.62–
0.74)31 36 38 45 46 and two studies showed almost perfect
inter-rater reliability (κ=0.85–0.89).37 44 The mean κ and
pooled κ are 0.65 (SD 0.19), meaning that the overall
inter-rater reliability of the GTT is substantial.23
Reliability of the HMPS
The percentage agreement of AE assessment was
reported in 10 studies and ranged from 73% to 91%
with a mean of 83% (SD 6.1%);3 11 39–42 49 50 52–54 per-
centage agreement for preventability of AE was assessed
in six studies and ranged from 58% to 93% with a mean
of 81% (SD 13%)3 11 39 40 49 54 (see online supplemen-
tary appendix 5).
Ten studies showed moderate inter-rater reliability for
AE detection (κ=0.40–0.57)32 39 41 42 48–52 54 and in four
studies the inter-rater reliability was substantial (κ=0.61–
0.80).3 11 40 49 In 10 studies, the κ for assessing prevent-
able AEs was reported and ranged from 0.19 to
0.76.3 11 32 39 40 48 49 51 53 54 One study showed slight
inter-rater reliability (κ=0.19),53 three studies showed
fair inter-rater reliability (κ=0.24–0.34),3 32 54 three
studies showed moderate inter-rater reliability (κ=0.44–
0.49)11 39 48 and three studies showed substantial inter-
rater reliability (κ=0.69–0.76)40 49 51 for assessing pre-
ventable AEs. The mean κ and pooled κ of the HMPS
for AE assessment are 0.54 (SD 0.10) and 0.55 (SD
0.07), respectively, and, for assessing preventability, they
are 0.47 (SD 0.20) and 0.48 (SD 0.20), respectively. The
inter-rater reliability of the HMPS is classiﬁed as
moderate.23
Subgroup analysis inter-rater reliability
The number of GTT studies (n=9) and HMPS studies
(n=11) were too small to perform the subgroup analysis
for the methods separately. Therefore, we used the κ sta-
tistics of all studies (n=20) to carry out the subgroup
analysis. The assumptions for ANCOVA were met.
Prevalence was not statistically signiﬁcant associated with
the κ values (p=0.069, p=0.189 and p=0.726, respect-
ively). We found a statistically signiﬁcant difference in
the pooled κ values, p=0.006, among subgroups accord-
ing to the number of reviewers (table 3). There were no
differences in κ values between subgroups according to
reviewer experience (p=0.062) and reviewer training
Table 3 Differences in pooled κ values (n=20) among subgroups according to number of reviewers, reviewer experience
and reviewer training
n Pooled κ* (SD) 95% CI p Value†
Group of reviewers
Max 5 7 0.80 (0.07) 0.66 to 0.94 0.006
>5–20 7 0.52 (0.06) 0.40 to 0.64
>20 6 0.54 (0.02) 0.50 to 0.59
Total 20
Reviewer experience (records/reviewer)
<100 7 0.71 (0.06) 0.58 to 0.84 0.062
100–300 6 0.51 (0.04) 0.43 to 0.58
>300 7 0.53 (0.04) 0.45 to 0.62
Total 20
Training
<1 day 4 0.53 (0.07) 0.37 to 0.68 0.809
1 day 4 0.56 (0.14) 0.25 to 0.87
>1 day 5 0.57 (0.05) 0.45 to 0.67
Total 13
*Pooled κ weighted for the number of records on which the κ value is calculated.
†p Values are obtained with the prevalence rate as covariate.
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(p=0.809). The group of maximum ﬁve reviewers
detected more AEs (average 17.1%) in comparison with
the other two groups of reviewers (table 4). This group
received the least training (median 6 hours) and
assessed the largest number of records (median 213
records). There was no signiﬁcant difference in the
reviewer experience (p=0.351), the reviewer training
(p=0.317) and the prevalence of AEs (p=0.480) between
the three groups of reviewers (maximum 5 reviewers,
>5–20 reviewers and >20 reviewers).
The number of studies that reported the κ of prevent-
able AEs (n=8) was too small for subgroup analysis. The
aim of the study and the type of instrument (GTT vs
HMPS) were not statistically signiﬁcantly associated with
κ (p=0.572 and p=0.086, respectively).
Validity
The face validity of the HMPS was reported in one study
as being a valid method to identify AEs.32 We found no
studies in which the concurrent validity of the GTT or
HMPS has been studied.
DISCUSSION
The inter-rater reliability of record review to detect AEs
is moderate to substantial;23 with a pooled κ of 0.65 and
0.55 for the GTT method and the HMPS method,
respectively. The pooled κ for preventability, measured
with the HMPS method, is moderate, 0.48. The fact that
there are no studies looking at concurrent validity is
alarming, given the statements that record review is
accepted worldwide as the ‘best’ means of measuring
incidence rates of AEs (even called ‘the gold stand-
ard’).15 59 Even if the inter-rater reliability of record
review is acceptable, there is no evidence that record
review really detects AEs. Possible methods to test the
concurrent validity of record review are clinical data
registries, autopsy or direct observations of patient care.
No single, even a small study experimented with above
listed reference methods, although these methods
capture valuable (real-time), accurate and precise
patient data.13 60–63
We found statistically signiﬁcant higher inter-rater reli-
ability in subgroups in which the group of reviewers con-
sisted of ﬁve reviewers or less. An explanation for this
difference is that when the group of reviewers is small,
the assessment of the presence of an AE becomes more
standardised.40 64 Having a small group of reviewers sti-
mulates (un)intentionally working closer together,
resulting in less variation in the review methodology and
more consensus about the deﬁnition of what constitutes
harm in order to be counted as an AE. Additional
advantages of having a small group of reviewers are that
intensive review training can be organised, and the
review process can be better monitored.40 In our review
however, the group of maximum ﬁve reviewers received
less training hours. Probably, they were better supervised
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or communicate better with each other during the
study, which could increase the inter-rater agreement.
The inter-rater reliability was higher when reviewers
assess a substantial number of records.40 We found no
statistically signiﬁcant differences between subgroups
according to reviewer experience, despite the group of
maximum ﬁve reviewers assessed a notable number of
records compared to the groups of reviewers, which
consist of 6–20 reviewers or more than 20 reviewers.
From other studies, we know that training improves
the performance of review teams and the application of
record review.65 66 We found no evidence for this in our
review. In fact, the group of maximum ﬁve reviewers had
half the training hours compared to the group of 6–20
reviewers but achieved a higher inter-rater agreement.
The systematic review of Lilford et al16 showed that
there was an association between κ and the prevalence
of AEs. We found no statistically signiﬁcantly association
between κ and the prevalence of AEs. The smaller range
of the prevalence rate (2.9–27.0%) in our review com-
pared to the review of Lilford et al16 (2.8–58.9%) could
explain why we did not ﬁnd an association between κ
and the prevalence of AEs.
Our systematic review has some strengths and limita-
tions. First, the evidence of the results of the statistical
pooling depends on the quality of the therein contained
studies. We used the validated COSMIN tool20 to evalu-
ate the methodological quality of the included studies.
Second, it was not possible to formally estimate the
pooled κ statistics for the GTT and Medical Record
Review (MRR) to assess between-study heterogeneity or
to carry out analyses of the likelihood of publication
bias, because CIs were lacking in approximately half of
the reliability studies. Third, the subgroup analyses were
limited to the variables that were reported by the
authors in the included studies of our systematic review.
Other factors that possibly inﬂuence the inter-rater
agreement between reviewers, such as the level of
cooperation between the reviewers during the review
process, could therefore not be studied. Fourth, our
review may have been inﬂuenced by publication bias, as
studies reporting low reliability or validity may be less
likely to be published than those with more positive
results. Fifth, we statistically pooled the κ values.
However, speciﬁc agreement on the presence of AE,
expressing the agreement separately for the positive and
negative ratings, is recommended.67 After all, inter-rater
reliability concerns when one reviewer ﬁnds an AE, and
this AE is also found by a second reviewer.
Unfortunately, in most of the studies, information about
the number of records for which there was agreement,
presented in a 2×2 cross table, was missing. Therefore,
we could not perform a statistical pooling of the propor-
tion of speciﬁc agreement.
In conclusion, users of the record review method to
assess (preventable) AEs should be aware that the inter-
rater agreement between reviewers is moderate to sub-
stantial and increases when using a smaller group of
reviewers. More studies are needed to explore which
factors increase the inter-rater reliability of record
review. Most importantly, concurrent validity should be
tested, otherwise it remains an imperfect, never evalu-
ated method.
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